Advertisement
News
Subscribe to MDT Magazine News

UPMC-Developed Test Increases Odds of Correct Surgery for Thyroid Cancer Patients

July 25, 2014 10:00 am | by UPMC/University of Pittsburgh Schools of the Health Sciences | Comments

Researchers have identified certain gene mutations that are indicative of an increased likelihood of thyroid cancer, and the molecular testing panel developed at UPMC can be run using the sample collected through the initial, minimally invasive biopsy, rather than a lobectomy. When the panel shows these mutations, a total thyroidectomy is advised.

TOPICS:

New imaging agent provides better picture of the gut

July 25, 2014 9:44 am | by EurekAlert! | Comments

A multi-institutional team of researchers has developed a new nanoscale agent for imaging the gastrointestinal (GI) tract. This safe, noninvasive method for assessing the function and properties of the GI tract in real time could lead to better diagnosis and treatment of gut diseases.

TOPICS:

TGen-led study seeks to understand why some HIV-positive men are more infectious than others

July 25, 2014 9:18 am | by Translational Genomics Research Institute | Comments

A new study led by the Translational Genomics Research Institute (TGen) provides insights into the interplay among bacteria, viruses and the immune system during HIV infection. Currently, doctors measure HIV-positive men's infectivity - their potential to infect others - based on their blood viral load. However, some men produce large amounts of virus in their semen despite having low levels in their blood.

TOPICS:
Advertisement

Guided Therapeutics Files PMA Amendment with FDA for LuViva® Advanced Cervical Scan

July 25, 2014 8:32 am | by The Associated Press | Comments

NORCROSS, Ga.--(BUSINESS WIRE)--Jul 25, 2014--Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that it has filed an amendment to its premarket approval (PMA) application with the U.S. Food and Drug Administration (FDA) for the LuViva ® Advanced Cervical Scan. The filing...

Gene Changes in Breast Cancer Cells Pinpointed with New Computational Method

July 24, 2014 3:07 pm | by Carnegie Mellon University | Comments

Computer scientists at Carnegie Mellon University, working with high-throughput data generated by breast cancer biologists at Lawrence Berkeley National Laboratory, have devised a computational method to determine how gene networks are...

TOPICS:

Test To Screen Donors of Blood, Tissues, and Organs for Hepatitis E Virus Receives CE Mark

July 24, 2014 2:27 pm | by Grifols | Comments

Grifols, one of the world’s leading companies in the plasma-derived biological medicines and transfusion medicine sectors, has announced CE mark for the Procleix HEV assay. The test, developed in collaboration with Hologic, Inc. (HOLX)...

TOPICS:

FDA 510(k) Clearance for Philips’ Ultra Mobile VISIQ Ultrasound System

July 24, 2014 12:15 pm | by PR Newswire | Comments

Royal Philips has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its innovative ultra mobile ultrasound system, VISIQ, in the U.S. VISIQ is the first Philips ultrasound system to combine...

TOPICS:

Natural Products from Plants Protect Skin During Cancer Radiotherapy

July 24, 2014 11:48 am | by Inderscience Publishers | Comments

Radiotherapy for cancer involves exposing the patient or their tumor more directly to ionizing radiation, such as gamma rays or X-rays. The radiation damages the cancer cells irreparably. Unfortunately, such radiation is also harmful to...

TOPICS:
Advertisement

Laser Therapy for Treatment of Transected Sciatic Nerve

July 24, 2014 11:38 am | by Neural Regeneration Research | Comments

Researchers at Central Taiwan University of Science and Technology, Taiwan, led by Prof. Liu, Dr. Shen and Mrs. Yang have developed a biodegradable nerve conduit containing genipin-cross-linked gelatin was annexed using beta-tricalcium...

TOPICS:

Philips to Expand Technology Platforms for Diagnostic Testing with Acquisition of Unisensor

July 24, 2014 9:50 am | by Royal Philips | Comments

Royal Philips has announced that it has signed an agreement to acquire Unisensor, an innovator in the field of optical analysis of fluids for diagnostic applications in health care, as well as other industries. The Unisensor technology and...

TOPICS:

FDA Clearance of Spectranetics’ Peripheral Laser Atherectomy Devices for In-Stent Restenosis

July 24, 2014 9:47 am | by Globe Newswire | Comments

The Spectranetics Corporation has announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of their peripheral atherectomy products, Turbo-Tandem and Turbo Elite, for the treatment of in-stent restenosis (ISR). The...

TOPICS:

Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent

July 24, 2014 9:42 am | by The Associated Press | Comments

To help health care organizations better understand trends in the cardiovascular market that could impact patient care and the bottom line, Novation released its Spring 2014 CV Watch, "Innovations in Cardiovascular Devices." The semi-annual...

TOPICS:

Sonosim Livescan Injects Stark Realism into Medical Simulation

July 24, 2014 9:41 am | by PR Newswire | Comments

SonoSim, Inc., a leading provider of ultrasound education and training, announced today the release of SonoSim LiveScan, the first ultrasound simulation technology to transform volunteers and standard mannequins into high-fidelity ultrasound...

TOPICS:

Misonix Enhances its Digital Presence with the Unveiling of its New BoneScalpelT App

July 24, 2014 9:36 am | by The Associated Press | Comments

Misonix, Inc., an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic...

TOPICS:

Introducing First-of-a-Kind PhysIQ Predictive Analytic Technology for Proactive Health Monitoring

July 24, 2014 9:36 am | by The Associated Press | Comments

PhysIQ has announced the company launch based on its proprietary predictive analytic technology for human physiology. PhysIQ is the first patient-centered predictive analytics platform for both the regulated Healthcare and unregulated Health...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading